TheFly.com
Start Free Trial
<
Back to all Breaking News
MBRX
12/1/2021 10:12am
3
Street Research Stories
1
Calendar Events
chevron_right
Roth Capital bullish on Moleculin as FDA clears WP1122 for Phase 1 GBM trial
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.
Join Now
Learn More
Already have an account?
Sign In Here
Subscription Rates
dynamic_feed
Breaking News
search
Search
menu
Menu
